Light therapy to ease chemotherapy hand-foot skin reaction
Part of Cancer, Skin clinical trials.
This study tests whether a light-based therapy (photobiomodulation) can reduce pain and skin irritation from hand-foot syndrome/hand-foot skin reaction in people getting chemotherapy or targeted medicines. It may help you heal sooner and feel more comfortable while treatment continues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have cancer and you’re currently getting chemotherapy or a targeted pill/injection (like a TKI).
- You already have hand-foot syndrome or hand-foot skin reaction that is mild to moderate (grade 1–3).
- You can follow the study plan and attend visits.
- You can sign a consent form to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if electroacupuncture combined with self-administered acupressure can prevent hand-foot syndrome, a common side effect of the chemotherapy drug capecitabine. It is for people with gastrointestinal or breast cancer who are starting capecitabine for the first time.
This study tests a light treatment (photobiomodulation) to see if it can help prevent or reduce nerve pain and numbness that can happen during cancer treatment. It is for people who are starting or receiving cancer therapy and do not already have nerve problems.
This trial studies whether a noninvasive light-based treatment (photobiomodulation) can reduce breast cancer–related lymphedema, which is swelling in the arm or chest area due to lymph fluid buildup. If you qualify, you’ll be asked to follow a set treatment and follow-up schedule to see if symptoms improve safely.
This study tests a plaster containing urea to see if it helps treat hand-foot syndrome, a common side effect of chemotherapy that causes redness, swelling, and pain on the hands and feet. It is for people with mild to moderate symptoms who are otherwise doing well.
This trial tests a traditional Chinese medicine hand-foot soak to help with painful side effects of cancer treatment, like hand-foot syndrome and nerve damage in hands or feet. If it works, it could make daily activities more comfortable and improve your quality of life.
This study tests a gel called TAR-0520 for hand and foot syndrome, a painful skin condition that can be caused by the chemotherapy drug capecitabine. The gel is applied to the hands and feet to see if it helps prevent or reduce this side effect.
Hear when a new Hand-foot Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.